Spanish-language VISs
Out-of-date
The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version of
the following VISs.
You are
encouraged to distribute the up-to-date
English-language VIS
at the same time as the translation.
These translations do not
contain the following CDC updates:
- Information was added about MMRV vaccine, tied to the
March 14 MMWR, regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR and
varicella vaccines given separately. Aside from two boxes containing
information about MMRV, both VISs are identical to the previous
editions.
- The new VISs should be used when MMRV is given; but the existing
stocks of the individual MMR and varicella VISs may be used when the
vaccines are given separately.
These translations do not
contain the following CDC updates:
- Information was added about MMRV vaccine, tied to the
March 14 MMWR, regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR and
varicella vaccines given separately. Aside from two boxes containing
information about MMRV, both VISs are identical to the previous
editions.
- The new VISs should be used when MMRV is given; but the existing
stocks of the individual MMR and varicella VISs may be used when the
vaccines are given separately.
This translation does not contain the
following CDC updates:
- The timing of the last
three doses in the 6-dose series has been clarified: 6, 12, and 18
months after the first dose").
- The website of the
Vaccine Adverse Event Reporting System has been added.
These translations do not contain the
following CDC updates:
- The meningococcal VIS has been updated slightly to incorporate
ACIP's new recommendation to vaccinate all children & adolescents
11-18 years of age. The new VIS is dated (8/16/07); the change
affects only the first 2 paragraphs of Section 3. In the VIS News
link on the CDC website they say that providers needn't discard
existing stocks of the previous edition, but should be prepared to
explain the updated recommendation to their patients if they use
the older version.
- The Guillain-Barre
Syndrome (second bullet just above section 6) was changed
slightly: "a few" was replaced by "some" to reflect the additional
cases that were reported.
You will be linked to the CDC
website, to download the Smallpox pre-vaccination information
packet, which includes the Smallpox VIS.
Please note: there are supplements that come
with this VIS, but the supplements have not been translated,
just the VIS.
Thanks to
the Minnesota Department of Health and the California Department
of Health Services for their translations.This page was updated on
March 13, 2008 |
Immunization Action Coalition
IAC Home